Zotiraciclib citrate clinical trials
A product of Zotiraciclib; its studies count on that page too.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How each study uses zotiraciclib citrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- TG02 citrate
- 3
Studies by the year they started
3 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Tragara Pharmaceuticals, Inc. (2) · Lee's Pharmaceutical Limited (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Zotiraciclib
- One of Protein Kinase Inhibitors source
Studies
Open first, then newest update. How each study uses zotiraciclib citrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study of TG02 Citrate in Patients With Advanced Hepatocellular CarcinomaWithdrawnPhase 1Lee's Pharmaceutical LimitedNCT03738111Written as TG02 Citrate
- Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCompletedPhase 1Tragara Pharmaceuticals, Inc.NCT01699152Written as TG02 citrate
- Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological MalignanciesCompletedPhase 1Tragara Pharmaceuticals, Inc.NCT01204164Written as TG02 citrate
Codes
What other systems call zotiraciclib citrate · ClinicalTrials.gg INT014743
- UNII (FDA) 3VF50SU4RZZOTIRACICLIB CITRATEOne source FDA
- NCI Thesaurus C105851Zotiraciclib CitrateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3VF50SU4RZ | ZOTIRACICLIB CITRATE | One source FDA |
| NCI Thesaurus | C105851 | Zotiraciclib Citrate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.